Do you want to read an article? Please log in or register.
What we have learned from the Ocular Hypertension Treatment Study
Cornea and Corneal DiseasesGlaucoma and Ocular Pressure
Related content
COMMENTED
Glaucoma and Ocular Pressure
Assessment of Cumulative Incidence and Severity of Primary Open-Angle Glaucoma Among Participants in the Ocular Hypertension Treatment Study After 20 Years of Follow-up
★ 3
Recommended and commented by
Prof. Dr emer. Josef Flammer, Faculty Member
★ 2
Recommended by
Dr Katarzyna Konieczka, Faculty Member
JAMA Ophthalmol
Kass MA, Heuer DK, Higginbotham EJ, Parrish RK, Khanna CL, Brandt JD, Soltau JB, Johnson CA, Keltner JL, Huecker JB, Wilson BS, Liu L, Miller JP, Quigley HA, Gordon MO, Ocular Hypertension Study Group.
doi: 10.1001/jamaophthalmol.2021.0341
Glaucoma and Ocular PressureOcular Oncology
Cataract surgery lowers intraocular pressure and medication use in the Medication Group of the Ocular Hypertension Treatment Study
Am J Ophthalmol
Mansberger SL, Gardiner SK, Gordon M, Kass M, Ramulu P, Ocular Hypertension Treatment Study group.
doi: 10.1016/j.ajo.2021.07.008
Cornea and Corneal DiseasesGlaucoma and Ocular PressureOcular Oncology
Thirteen-Year Follow-up of Optic Disc Hemorrhages in the Ocular Hypertension Treatment Study
Am J Ophthalmol.
Budenz DL, Huecker JB, Gedde SJ, Gordon M, Kass M; Ocular Hypertension Treatment Study Group
doi: 10.1016/
COMMENTED
Glaucoma and Ocular Pressure
Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial
Lancet.
Gazzard G, Konstantakopoulou E, Garway-Heath D, Garg A, Vickerstaff V, Hunter R, Ambler G, Bunce C,
Wormald R, Nathwani N, Barton K, Rubin G, Buszewicz M, LiGHT Trial Study Group
doi: 10.1016/S0140-6736(18)32213-X.
Cornea and Corneal DiseasesGlaucoma and Ocular PressureOcular OncologyRetinal DiseasesSurgery and Intervention
Rho Kinase Inhibitors as a Novel Treatment for Glaucoma and Ocular Hypertension
Ophthalmology.
Tanna AP, Johnson M
doi: 10.1016/j.ophtha.2018.04.040.
Glaucoma and Ocular PressureRetinal DiseasesUveitis
Risk of Ocular Hypertension in Adults with Noninfectious Uveitis
Ophthalmology.
Daniel E, Pistilli M, Kothari S, Khachatryan N, Kaçmaz RO, Gangaputra SS, Sen HN, Suhler EB, Thorne JE, Foster CS, Jabs DA, Nussenblatt RB, Rosenbaum JT, Levy-Clarke GA, Bhatt NP, Kempen JH; Systemic Immunosuppressive Therapy for Eye Diseases Research Group
doi: 10.1016/j.ophtha.2017.03.041.
COMMENTED
Glaucoma and Ocular Pressure
Primary Selective Laser Trabeculoplasty for Open Angle Glaucoma and Ocular Hypertension: Clinical Outcomes, Predictors of Success and Safety from the Laser in Glaucoma and Ocular Hypertension (LiGHT) Trial
Ophthalmology.
Garg A, Vickerstaff V, Nathwani N, Garway-Heath D, Konstantakopoulou E, Ambler G, Bunce C, Wormald R, Barton K, Gazzard G, LiGHT Trial Study Group.
doi: 10.1016/
Glaucoma and Ocular Pressure
LATE-ONSET OCULAR HYPERTENSION AFTER VITRECTOMY: A Multicenter Study of 6,048 Eyes
Retina.
Reibaldi M, Avitabile T, Russo A, Bonfiglio V, Mariotti C, Romano MR, Boscia F, Cennamo G, Fallico M, Parisi G, Castellino N, Bucolo C, Li Volti G, Longo A
doi: 10.1097/IAE.
COMMENTED
Glaucoma and Ocular Pressure
The genetic influence on corticosteroid-induced ocular hypertension: A field positioned for discovery
Am J Ophthalmol.
Chan W, Wiggs JL, Sobrin L
doi: 10.1016/j.ajo.